antibiot
use
anim
agricultur
growth
promot
subtherapeut
dose
diseas
prevent
prophylact
dose
treatment
infect
year
turner
et
al
year
research
practic
experi
shown
antibiot
use
significantli
improv
anim
perform
health
statu
cromwel
howev
use
misus
infe
antibiot
led
problem
drug
residu
anim
product
increas
bacteri
resist
khachatourian
result
subtherapeut
use
antibiot
total
ban
european
countri
sinc
januari
casewel
et
al
countri
serious
consid
similar
ban
therefor
altern
antibiot
urgent
need
wide
rang
product
test
potenti
altern
antibiot
includ
organ
inorgan
acid
kim
et
al
oligosaccharid
flicking
et
al
probiot
krita
morrison
tara
et
al
herbal
extract
windisch
et
al
antibodi
cook
among
oral
immunotherapi
passiv
immun
antibodi
highli
attract
effect
altern
approach
due
high
specif
oral
administr
antibodi
deriv
mammalian
serum
colostrum
even
monoclon
antibodi
use
success
kuhlman
et
al
howev
techniqu
prohibit
expens
obtain
larg
amount
antibodi
requir
prevent
treat
diseas
recent
chicken
egg
yolk
immunoglobulin
refer
immunoglobulin
igi
attract
consider
attent
mean
prevent
control
diseas
possess
larg
number
advantag
compar
treatment
mammalian
igg
includ
costeffect
conveni
high
yield
carland
et
al
natur
condit
serum
igi
lay
hen
deposit
larg
quantiti
egg
yolk
order
protect
develop
embryo
potenti
pathogen
janson
et
al
thu
possibl
immun
hen
specif
foreign
pathogen
therebi
allow
product
igi
activ
specif
diseas
condit
oral
administr
specif
igi
antibodi
shown
effect
varieti
intestin
pathogen
bovin
human
rotavirus
enterotoxigen
escherichia
coli
etec
bovin
coronaviru
salmonella
spp
edwardsiella
tarda
yersinia
ruckeri
staphylococcu
pseudomona
mine
kovacsnolan
review
present
overview
potenti
use
immunotherapi
specif
igi
prevent
treatment
terrestri
aquat
anim
diseas
specul
futur
igi
technolog
use
chicken
product
polyclon
antibodi
provid
mani
advantag
product
method
use
mammal
tabl
signific
advantag
collect
antibodi
noninvas
contrast
convent
method
anim
often
sacrif
order
collect
suffici
amount
blood
obtain
antibodi
product
antibodi
lay
hen
requir
collect
egg
high
longlast
titer
produc
chicken
reduc
need
frequent
booster
inject
anoth
advantag
due
phylogenet
distanc
chicken
mammal
chicken
often
success
produc
antibodi
highli
conserv
mammalian
protein
mammal
requir
much
less
antigen
induc
effici
immun
respons
hen
consid
small
factori
antibodi
product
hen
usual
lay
egg
per
year
egg
yolk
ml
contain
mg
igi
specif
antibodi
rose
et
al
therefor
one
immun
hen
produc
mg
igi
per
year
equival
product
rabbit
cours
year
schade
et
al
mainten
cost
keep
hen
also
lower
mammal
rabbit
schade
et
al
therefor
egg
yolk
provid
hygien
costeffici
conveni
rich
sourc
antibodi
compar
tradit
method
obtain
antibodi
mammalian
serum
contrast
antibiot
use
igi
environmentallyfriendli
elicit
undesir
side
effect
diseas
resist
toxic
residu
coleman
initi
igi
antibodi
thought
similar
igg
immunoglobulin
wherea
consid
evolutionari
ancestor
mammalian
igg
ige
also
iga
warr
et
al
although
chicken
igi
function
equival
mammalian
igg
profound
differ
structur
gener
structur
igi
molecul
igg
molecul
two
heavi
h
chain
two
light
l
chain
igi
molecular
mass
kda
larger
mammalian
igg
kda
fig
molecular
mass
kda
h
chain
igi
larger
h
chain
mammal
kda
greater
molecular
mass
igi
due
increas
number
heavychain
constant
domain
carbohydr
chain
warr
et
al
igg
c
region
c
igi
c
region
c
presenc
one
addit
c
region
two
correspond
carbohydr
chain
logic
result
greater
molecular
mass
igi
compar
igg
differ
structur
includ
fact
hing
region
igi
much
less
flexibl
compar
mammalian
igg
also
suggest
igi
hydrophob
molecul
igg
davalospantoja
et
al
final
igi
isoelectr
point
ph
wherea
igg
lie
davalospantoja
et
al
sun
et
al
unlik
mammalian
igg
igi
fix
mammalian
complement
interact
mammalian
fc
complement
receptor
carland
et
al
well
igi
bind
protein
protein
g
rheumatoid
factor
fals
posit
obtain
immunoassay
problem
iggbas
mammalian
assay
davalospantoja
et
al
differ
provid
signific
advantag
applic
igi
technolog
mani
area
research
diagnost
erhard
et
al
antibioticaltern
therapi
carland
et
al
xenotransplant
fryer
et
al
stabil
igi
storag
reason
good
specifi
condit
igi
solut
may
store
period
rang
month
year
provid
nan
wv
thimeros
gentamicin
ad
retard
microbi
growth
schade
et
al
dri
igi
prepar
store
five
ten
year
without
signific
loss
antibodi
activ
prepar
also
retain
activ
six
month
room
temperatur
one
month
larsson
et
al
lyophil
minim
bacteri
growth
maintain
better
structur
integr
purifi
igi
spraydri
econom
collect
uniqu
biolog
attribut
make
igi
effect
natur
food
antimicrobi
system
immunotherapeut
agent
exact
mechan
igi
counteract
pathogen
activ
determin
howev
sever
mechan
propos
express
specif
igi
counteract
pathogen
activ
outlin
agglutin
tsubokura
et
al
suggest
inhibit
bacteri
growth
colon
observ
result
treatment
igi
result
bacteri
agglutin
caus
reduct
cfu
rather
actual
direct
effect
individu
bacteria
although
agglutin
may
one
mediat
growth
inhibit
unlik
import
mediat
crosslink
bacteria
preclud
steric
hindranc
two
fab
arm
igi
gallagh
voss
ii
adherenceblockad
sever
vitro
studi
suggest
inhibit
adhes
domin
mechan
specif
igi
counteract
pathogen
activ
jin
et
al
lee
et
al
jin
et
al
show
igi
function
prevent
adher
e
coli
intestin
mucu
piglet
particular
compon
expos
gramneg
bacteria
surfac
outer
membran
protein
lipopolysaccharid
fimbria
pili
flagella
crucial
factor
bacteri
colon
may
recogn
bound
relat
polyclon
antibodi
igi
sim
et
al
bind
may
block
impair
function
growthrel
bacteri
compon
lead
bacteri
growth
inhibit
also
possibl
specif
igi
bind
bacteria
could
alter
cellular
signal
cascad
could
result
decreas
toxin
product
releas
iii
opson
follow
phagocytosi
nie
et
al
determin
igi
improv
phagocytosi
aureu
neutrophil
similarli
zhen
et
al
show
phagocyt
activ
e
coli
either
milk
macrophag
polymorphonuclear
neutrophil
leukocyt
increas
significantli
presenc
igi
result
suggest
igi
enhanc
phagocyt
activ
structur
alter
observ
surfac
typhimurium
e
coli
zhen
et
al
bind
specif
igi
chang
could
explain
variat
electron
cloud
andor
electr
field
bacteri
surfac
result
greater
vulner
bacteri
cell
phagocytosi
iv
toxin
neutral
aureu
capsular
major
virul
factor
involv
onset
bovin
mastiti
wang
et
al
studi
effect
igi
encapsul
aureu
result
show
igi
could
prevent
aureu
intern
mammari
epitheli
cell
suggest
toxin
neutral
activ
rather
direct
growth
inhibit
mean
igi
act
control
mastiti
potenti
applic
use
oral
administ
igi
control
enter
nonenter
infect
either
bacteri
viral
origin
human
anim
studi
length
summar
tabl
bovin
mastiti
costli
diseas
dairi
industri
unit
state
alon
annual
cost
mastiti
estim
billion
us
numer
pathogen
caus
mastiti
classifi
contagi
pathogen
primari
staphylococcu
aureu
streptococcu
agalactia
environment
pathogen
primari
e
coli
riffon
et
al
research
report
specif
igi
produc
hen
immun
aureu
andor
e
coli
effect
control
experiment
clinic
mastiti
zhen
et
al
b
vitro
studi
conduct
laboratori
indic
igi
could
inhibit
growth
bacteria
alter
bacteri
cell
surfac
therebi
reduc
abil
bacteria
adher
mammari
epitheli
cell
zhen
et
al
studi
efficaci
specif
igi
reduc
clinic
experiment
mastiti
caus
aureu
demonstr
improv
milk
qualiti
decreas
somat
cell
bacteri
count
milk
cure
rate
result
use
igi
clinic
experiment
mastiti
dramat
higher
untreat
anim
tabl
although
conduct
anim
narat
studi
indic
specif
igi
consider
potenti
therapeut
treatment
mastiti
dairi
cow
enterotoxigen
e
coli
etec
far
common
caus
enter
colibacillosi
encount
neonat
postwean
pig
strain
e
coli
associ
intestin
colon
caus
sever
diarrhea
fimbrial
adhesin
among
etec
express
fimbrial
antigen
preval
form
caus
e
coli
infect
worldwid
rapacz
haslerrapacz
estim
etec
respons
half
piglet
mortal
occur
year
water
sellwood
caus
signific
econom
loss
pig
industri
igi
recogn
altern
sourc
antibodi
prevent
etec
coli
infect
found
inhibit
bind
e
coli
intestin
mucosa
jin
et
al
igi
oral
administ
piglet
offer
potenti
prophylact
therapeut
approach
control
e
coliinduc
diarrhea
yokoyama
et
al
show
oral
administ
igi
gener
e
coli
fimbria
protect
infect
three
homolog
strain
e
coli
dosedepend
manner
e
coli
strain
adher
equal
porcin
epitheli
cell
duodenum
ileum
fail
presenc
homolog
antifimbri
igi
group
research
univers
manitoba
winnipeg
canada
carri
excel
studi
passiv
protect
effect
igi
etec
fimbria
control
neonat
earlywean
piglet
vitro
vivo
jin
et
al
marquardt
et
al
anim
feed
studi
old
pig
challeng
ml
etec
dose
cfu
ml
per
piglet
igi
administ
piglet
three
time
day
two
day
control
piglet
treat
igi
nonimmun
hen
develop
sever
diarrhea
within
h
pig
die
contrast
pig
given
igi
immun
hen
exhibit
sign
diarrhea
observ
h
treatment
tabl
furthermor
field
studi
show
suppress
incid
sever
diarrhea
wean
piglet
fed
specif
igi
powder
much
lower
fed
commerci
diet
contain
antibiot
number
pig
studi
larg
would
desir
repeat
studi
greater
number
anim
tabl
investig
use
specif
igi
control
nonenter
diseas
effect
igi
ref
protect
rat
mutansinduc
dental
cari
hamada
et
al
snake
p
b
compar
treatment
group
ten
millilit
igi
concentr
mg
ml
penicillin
concentr
mg
ml
infus
mammari
gland
immedi
cow
morn
even
milk
six
consecut
day
b
mammari
gland
select
clinic
mastiti
treatment
met
follow
criteria
obviou
clinic
sign
mastiti
detect
aureu
count
milk
sampl
cfu
ml
somat
cell
count
cell
ml
c
mammari
gland
select
induc
experiment
mastiti
met
follow
criteria
clinic
sign
mastiti
detect
aureu
count
milk
less
cfu
ml
bacteria
detect
somat
cell
count
less
cfu
ml
experiment
mastiti
induc
mammari
infus
cfu
ml
aureu
piglet
challeng
oral
two
time
h
dose
cfu
ml
viabl
organ
per
piglet
piglet
e
coli
challeng
igi
group
treat
g
egg
yolk
antibodi
three
time
day
h
first
etec
challeng
first
day
day
next
two
day
first
etec
challeng
b
fc
score
mean
fecal
consist
score
normal
soft
fece
mild
diarrhea
sever
diarrhea
pig
fecal
score
consid
diarrhea
investig
use
specif
igi
control
enter
diseas
mine
kovacsnolan
effect
igi
ref
protect
calv
bovin
rotavirusinduc
diarrhea
kuroki
et
al
prevent
murin
rotaviru
mice
yolken
et
al
prevent
human
rotavirusinduc
gastroenter
mice
ebina
prevent
treatment
rotavirusinduc
gastroenter
murin
model
hatta
et
al
etec
caus
sever
diarrhea
young
anim
prolifer
small
intestin
product
two
type
enterotoxin
includ
heatlabil
enterotoxin
lt
famili
heatstabl
enterotoxin
st
includ
sta
stb
dubreuil
enterotoxin
crucial
virul
factor
therefor
effect
program
immunolog
protect
etecmedi
diarrhea
includ
antitox
immun
cardena
clement
small
size
enterotoxin
sta
stb
poorli
immunogen
attain
immunogen
coupl
chemic
genet
appropri
carrier
clement
dubreuil
et
al
antitoxin
antibodi
shown
import
prevent
e
coliinduc
diarrhea
consid
limit
number
class
enterotoxin
enterotoxinbas
vaccin
provid
broadspectrum
protect
variou
etec
order
make
use
toxoid
polyval
enterotoxin
staltbstb
dna
protein
vaccin
endow
immunogen
sta
stb
construct
immun
lay
hen
dna
vaccin
obtain
antitox
antibodi
egg
yolk
confirm
indirect
elisa
polyval
dna
vaccin
pcistaltbstb
express
staltbstb
fusion
peptid
vitro
cultur
hela
cell
egg
yolk
antibodi
abl
neutral
biolog
activ
st
lt
therefor
trival
fusion
enterotoxin
staltbstb
potenti
serv
use
toxinbas
vaccin
provid
broad
protect
etecinduc
diarrhea
neonat
calf
diarrhea
caus
bovin
rotaviru
brv
common
diseas
caus
high
mortal
cattl
lee
et
al
antibrv
igi
shown
success
provid
protect
brv
infect
calv
kuroki
et
al
bovin
corona
viru
bcv
import
enter
pathogen
respons
neonat
calf
diarrhea
acut
diarrhea
adult
cattl
bcv
may
sever
brv
replic
epithelium
small
larg
intestin
wherea
brv
infect
small
intestin
ikemori
et
al
examin
efficaci
specif
igi
antibodi
cow
colostrum
antibodi
bcvinduc
diarrhea
calv
found
control
calv
receiv
antibodi
develop
sever
diarrhea
result
calv
die
within
day
bcv
challeng
wherea
calv
treat
milk
contain
egg
yolk
colostrum
posit
weight
gain
none
calv
die
tabl
studi
conduct
anim
larger
studi
conduct
confirm
find
howev
result
indic
oral
administ
egg
yolk
colostr
antibodi
potenti
passiv
protect
calv
bcv
infect
effect
igi
higher
colostrum
alon
indic
passiv
immun
strategi
igi
provid
efficaci
altern
exist
treatment
bcv
passiv
protect
effect
use
antietec
igi
administr
fatal
enter
colibacillosi
neonat
calv
also
studi
calv
fed
milk
contain
igi
transient
diarrhea
surviv
exhibit
good
bodi
weight
gain
cours
studi
contrast
control
receiv
antibodi
sever
diarrhea
die
within
day
infect
salmonella
infect
thought
respons
varieti
acut
chronic
diseas
poultri
shown
specif
igi
salmonella
enteritidi
salmonella
typhimurium
inhibit
bacteri
growth
vitro
studi
demonstr
egg
deriv
anti
entritidi
igi
antibodi
benefici
effect
reduc
colon
salmonella
marketag
broiler
rahimi
et
al
tellez
et
al
tabl
whether
translat
improv
broiler
perform
determin
use
whole
egg
powder
contain
antibodi
feed
addit
may
altern
way
reduc
rate
salmonella
contamin
egg
gurtler
et
al
found
experiment
group
egg
salmonella
posit
significantli
lower
salmonellaposit
egg
control
group
p
tabl
howev
must
point
major
salmonella
found
shell
modest
differ
salmonella
number
albumen
yolk
whether
translat
less
health
risk
consum
egg
product
known
time
campylobact
jejuni
becom
major
concern
commerci
broiler
turkey
commerci
eggproduc
f
lock
countri
tsubokura
et
al
use
egg
yolk
antibodi
prophylact
therapeut
applic
campylobacterinfect
chicken
prophylaxi
experi
found
antibodi
caus
decreas
number
campylobact
observ
wherea
therapi
trial
antibodi
given
establish
infect
number
bacteria
fece
lower
unfortun
bird
perform
monitor
studi
infecti
bursal
diseas
ibd
acut
highli
contagi
diseas
young
chicken
caus
ibd
viru
chettl
et
al
earli
subclin
infect
usual
result
immunosuppress
import
form
diseas
larg
econom
loss
result
presenc
chicken
immunosuppress
earli
ibd
infect
respond
well
vaccin
tabl
clinic
respons
calv
challeng
exposur
bovin
coronaviru
subsequ
treatment
egg
yolk
powder
ikemori
et
al
show
increas
suscept
diseas
bacteri
infect
e
coli
viral
infect
like
bronchiti
inclus
bodi
hepat
muhammad
et
al
antibiot
therapi
readilyavail
approach
control
ibdinduc
secondari
bacteri
infect
affect
flock
shown
specif
igi
great
potenti
altern
antibiot
ibd
muhammad
et
al
demonstr
yolk
hyperimmun
hen
use
control
ibd
commerci
lay
hen
ibd
infect
broiler
day
old
treat
yolk
induc
recoveri
control
untreat
bird
die
newcastl
diseas
sever
viral
infect
caus
respiratori
nervou
disord
sever
speci
poultri
includ
chicken
turkey
diseas
endem
commerci
poultri
mani
countri
caus
great
econom
loss
due
high
mortal
rate
lancast
vaccin
use
prevent
diseas
endem
area
vaccin
alway
effect
vaccin
flock
may
still
infect
outbreak
newcastl
diseas
occur
commerci
poultri
flock
antibiot
may
given
prevent
secondari
bacteri
infect
usual
trigger
diseas
shown
egg
yolk
antibodi
confer
protect
chicken
newcastl
diseas
box
et
al
will
luginbuhl
will
luginbuhl
found
subcutan
administr
egg
yolk
contain
high
level
igi
antibodi
specif
newcastl
diseas
protect
bird
fourweek
studi
period
white
spot
syndrom
viru
wssv
virul
pathogen
caus
high
mortal
signific
econom
loss
cultur
shrimp
oper
worldwid
wongteerasupaya
et
al
invertebr
shrimp
lack
true
adapt
immun
respons
system
kimbrel
beutler
howev
shrimp
may
exhibit
quasiimmun
respons
possibl
show
wssvspecif
effect
witteveldt
et
al
wu
et
al
wssv
neutral
chicken
igi
produc
truncat
fusion
protein
kim
et
al
therefor
passiv
immun
igi
wssv
potenti
immunotherapeut
applic
prevent
wssv
infect
shrimp
research
demonstr
passiv
immun
antivir
egg
yolk
antibodi
igi
arasteh
et
al
kweon
et
al
howev
research
work
lu
et
al
repres
first
report
passiv
immun
shrimp
igi
obtain
egg
yolk
chicken
vaccin
dna
vaccin
compris
gene
encod
structur
protein
wssv
inactiv
wssv
work
show
igi
antibodi
high
affin
wssv
maintain
good
biolog
neutral
activ
especi
induc
tradit
inactiv
vaccin
igi
antibodi
induc
dna
vaccin
also
abl
neutral
diseas
shrimp
experiment
challeng
wssv
still
inferior
inactiv
wssv
lu
et
al
use
specif
igi
hen
immun
inactiv
wssv
dna
vaccin
neutral
wssv
challeng
shrimp
surviv
respect
fig
well
effect
igi
provid
intramuscular
inject
oral
administr
immers
investig
crayfish
procambiu
clarkiaii
challeng
wssv
lu
et
al
result
show
immun
specif
igi
antibodi
intramuscular
inject
oral
administr
immers
effect
mean
protect
crayfish
wssv
unfortun
labor
intens
techniqu
may
limit
applic
commerci
aquacultur
condit
crayfish
rais
ocean
egg
yolk
antibodi
harvest
cost
effici
conveni
manner
compar
product
antibodi
mammal
mine
kovacsnolan
igi
egg
yolk
could
prepar
differ
form
egg
yolk
powder
purifi
powder
liquor
may
provid
feasibl
signific
way
forward
research
use
antibodi
wssv
effect
igi
passiv
immun
rainbow
trout
ruckeri
infect
studi
ruckeri
aetiolog
agent
enter
red
mouth
diseas
system
bacteri
septicaemia
princip
affect
farm
rainbow
trout
oncorhynchu
mykiss
stevenson
et
al
ruckeri
could
persist
long
period
carrier
fish
shed
fece
repres
continu
sourc
infect
popul
asymptomat
carrier
fish
could
adequ
clear
oral
administr
antiy
ruckeri
antibodi
treatment
might
costeffect
altern
approach
slaughter
stock
fish
potenti
health
risk
rainbow
trout
fed
antiy
ruckeri
igi
h
immers
challeng
ruckeri
show
lower
mortal
rate
day
fish
fed
unsuppl
igi
feed
challeng
fish
fed
igi
also
appear
fewer
infect
day
base
organ
intestin
cultur
subsequ
trial
igyf
fish
lower
mortal
fish
receiv
unsuppl
igi
feed
percentag
igyf
fish
carri
ruckeri
intestin
sampl
appear
lower
untreat
control
regardless
whether
igi
contain
feed
given
challeng
oral
administr
specif
igi
fish
pathogen
could
provid
altern
method
antibiot
chemotherapi
prevent
bacteri
diseas
fish
fish
farm
e
tarda
anoth
import
fish
pathogen
spread
infect
intestin
mucosa
noga
edwardsiellosi
japanes
eel
becom
seriou
problem
eel
farm
industri
wakabayashi
egusa
egg
yolk
antibodi
investig
prevent
infecti
diseas
use
misus
antibiot
led
grow
problem
drug
residu
fish
product
increas
bacteri
resist
gutierrez
et
al
hatta
et
al
anti
tarda
igi
simultan
administ
oral
japanes
eel
anguilla
lu
et
al
japonica
pathogen
bacteria
cfu
per
fish
nontreat
infect
eel
die
within
day
wherea
eel
receiv
igi
surviv
diseas
symptom
observ
suggest
anti
tarda
igi
effect
prevent
edwardsiellosi
gutierrez
et
al
limit
number
eel
use
studi
repeat
greater
number
would
certainli
welcom
limit
use
igi
oral
passiv
immunotherapi
due
suscept
proteolysi
igi
fairli
resist
digest
intestin
proteas
shimizu
et
al
howev
found
activ
igi
decreas
ph
complet
lost
ph
shimizu
et
al
igi
serum
halflif
day
newborn
pig
shorter
report
serum
halflif
day
homolog
igg
colostr
antibodi
fraction
igi
absorb
circul
administ
pig
decreas
increas
age
pig
sinc
primari
target
site
igi
small
intestin
order
function
essenti
find
effect
method
protect
igi
peptic
digest
acid
stomach
shown
microencapsul
effect
method
protect
igi
gastric
inactiv
chang
et
al
cho
et
al
kovacsnolan
mine
li
et
al
li
et
al
process
undoubtedli
add
addit
cost
addit
studi
need
microencapsul
appli
commerci
condit
vitro
studi
demonstr
igi
effect
mani
gramneg
bacteria
contrast
inhibit
activ
igi
gramposit
bacteria
occasion
report
sugitakonishi
et
al
zhen
et
al
zhen
et
al
wang
et
al
may
due
fact
gramposit
bacteria
compact
cell
wall
compar
gramneg
bacteria
howev
clearli
limit
type
diseas
treat
igi
technolog
object
treatment
igi
alway
prevent
diseas
sometim
simpli
reduct
infecti
agent
kuroki
et
al
unlik
mammalian
igg
igi
bind
complement
act
opsonin
phagocytosi
therefor
igi
unabl
kill
bacteria
directli
also
shown
igi
antibodi
abl
displac
e
coli
mb
bound
mucos
receptor
indic
antibodi
lower
affin
receptor
fimbria
sinc
igi
could
remov
previous
bound
e
coli
mb
mucu
prophylact
use
igi
suggest
jin
et
al
howev
therapeut
effect
igi
control
infect
report
e
coli
piglet
wiedemann
et
al
c
jejuni
chicken
tsubokura
et
al
salmonella
mice
yokoyama
et
al
present
product
cost
high
qualiti
igi
antibodi
higher
cost
routin
antibiot
casadeval
scharff
therefor
develop
method
largescal
product
igi
high
recoveri
puriti
need
method
simpl
econom
requir
chemic
addit
consensu
suitabl
igi
extract
method
commerci
applic
schade
et
al
requir
studi
oral
administr
chicken
egg
yolk
immunoglobulin
appear
consider
potenti
mean
control
infecti
diseas
bacteri
viral
origin
may
diseas
treatment
futur
date
igi
technolog
use
treatment
livestock
diseas
mastiti
diarrhea
poultri
diseas
salmonella
campylobacteriosi
infecti
bursal
diseas
newcastl
diseas
well
aquat
diseas
like
shrimp
white
spot
syndrom
viru
ruckeri
e
tarda
advantag
igi
control
anim
diseas
highli
effect
cost
effect
collect
egg
noninvas
treatment
safe
live
organ
use
procedur
environment
friendli
toxic
residu
produc
develop
resist
treatment
use
control
mani
differ
type
pathogen
